Matouk Bassiouny - in Association with AIH law firm | View firm profile
We are pleased to announce that Matouk Bassiouny & Hennawy (“MBH”) acted as the legal counsel to Triquera B.V. (“Triquera”), the majority shareholder of Minapharm Pharmaceuticals (“Minapharm”), in connection with the subscription of a minority stake by Admaius Capital Partners (“Admaius”), an Africa-focused private equity investor.
The investment—executed through Admaius’s investment vehicle, Virunga Healix Limited—is intended to support Minapharm’s regional biotech expansion. Triquera and Admaius will partner to advance the development and manufacture of complex genetically engineered therapies. The collaboration aims to broaden access to high-quality, affordable recombinant proteins, reflecting both parties’ commitment to innovation and inclusive healthcare by scaling distribution networks across underserved markets in Africa and the Middle East.
The MBH team advising on the transaction was led by Omar S. Bassiouny (Founding Partner and Group Head of Corporate and M&A) with support from Salma El Refaie (Senior Associate) and Mayar Sharafeldin (Associate).
For more about Matouk Bassiouny, check out our website at https://matoukbassiouny.com/.